File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/s00417-011-1764-z
- Scopus: eid_2-s2.0-80755172142
- PMID: 21866334
- WOS: WOS:000295129000002
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Promises of stem cell therapy for retinal degenerative diseases
Title | Promises of stem cell therapy for retinal degenerative diseases | ||||||
---|---|---|---|---|---|---|---|
Authors | |||||||
Keywords | Clinical applications Donor cells Method of cell delivery Potential risks Retinal degenerative diseases Stem cell therapy Target cell types | ||||||
Issue Date | 2011 | ||||||
Publisher | Springer Verlag. The Journal's web site is located at http://link.springer.de/link/service/journals/00417/index.htm | ||||||
Citation | Graefe's Archive For Clinical And Experimental Ophthalmology, 2011, v. 249 n. 10, p. 1439-1448 How to Cite? | ||||||
Abstract | With the development of stem cell technology, stem cell-based therapy for retinal degeneration has been proposed to restore the visual function. Many animal studies and some clinical trials have shown encouraging results of stem cell-based therapy in retinal degenerative diseases. While stem cell-based therapy is a promising strategy to replace damaged retinal cells and ultimately cure retinal degeneration, there are several important challenges which need to be overcome before stem cell technology can be applied widely in clinical settings. In this review, different types of donor cell origins used in retinal treatments, potential target cell types for therapy, methods of stem cell delivery to the eye, assessments of potential risks in stem cell therapy, as well as future developments of retinal stem cells therapy, will be discussed. | ||||||
Persistent Identifier | http://hdl.handle.net/10722/144872 | ||||||
ISSN | 2023 Impact Factor: 2.4 2023 SCImago Journal Rankings: 1.014 | ||||||
PubMed Central ID | |||||||
ISI Accession Number ID |
Funding Information: This work was supported by NSFC/RGC Joint Research Scheme (N_HKU 716/09 to Q Lian) and Small project funding from the University of Hong Kong (201007176100 to Q Lian). | ||||||
References | |||||||
Grants |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wong, IYH | en_HK |
dc.contributor.author | Poon, MW | en_HK |
dc.contributor.author | Pang, RTW | en_HK |
dc.contributor.author | Lian, Q | en_HK |
dc.contributor.author | Wong, D | en_HK |
dc.date.accessioned | 2012-02-21T05:43:43Z | - |
dc.date.available | 2012-02-21T05:43:43Z | - |
dc.date.issued | 2011 | en_HK |
dc.identifier.citation | Graefe's Archive For Clinical And Experimental Ophthalmology, 2011, v. 249 n. 10, p. 1439-1448 | en_HK |
dc.identifier.issn | 0721-832X | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/144872 | - |
dc.description.abstract | With the development of stem cell technology, stem cell-based therapy for retinal degeneration has been proposed to restore the visual function. Many animal studies and some clinical trials have shown encouraging results of stem cell-based therapy in retinal degenerative diseases. While stem cell-based therapy is a promising strategy to replace damaged retinal cells and ultimately cure retinal degeneration, there are several important challenges which need to be overcome before stem cell technology can be applied widely in clinical settings. In this review, different types of donor cell origins used in retinal treatments, potential target cell types for therapy, methods of stem cell delivery to the eye, assessments of potential risks in stem cell therapy, as well as future developments of retinal stem cells therapy, will be discussed. | en_HK |
dc.language | eng | en_US |
dc.publisher | Springer Verlag. The Journal's web site is located at http://link.springer.de/link/service/journals/00417/index.htm | en_HK |
dc.relation.ispartof | Graefe's Archive for Clinical and Experimental Ophthalmology | en_HK |
dc.rights | The Author(s) | en_US |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | en_US |
dc.subject | Clinical applications | en_HK |
dc.subject | Donor cells | en_HK |
dc.subject | Method of cell delivery | en_HK |
dc.subject | Potential risks | en_HK |
dc.subject | Retinal degenerative diseases | en_HK |
dc.subject | Stem cell therapy | en_HK |
dc.subject | Target cell types | en_HK |
dc.title | Promises of stem cell therapy for retinal degenerative diseases | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4551/resserv?sid=springerlink&genre=article&atitle=Promises of stem cell therapy for retinal degenerative diseases&title=Graefe's Archive for Clinical and Experimental Ophthalmology&issn=0721832X&date=2011-10-01&volume=249&issue=10& spage=1439&authors=Ian Yat-Hin Wong, Ming-Wai Poon, Rosita Tsz-Wai Pang, <i>et al.</i> | en_US |
dc.identifier.email | Wong, IYH: wongyhi@hku.hk | en_HK |
dc.identifier.email | Lian, Q: qzlian@hkucc.hku.hk | en_HK |
dc.identifier.email | Wong, D: shdwong@hku.hk | en_HK |
dc.identifier.authority | Wong, IYH=rp01467 | en_HK |
dc.identifier.authority | Lian, Q=rp00267 | en_HK |
dc.identifier.authority | Wong, D=rp00516 | en_HK |
dc.description.nature | published_or_final_version | en_US |
dc.identifier.doi | 10.1007/s00417-011-1764-z | en_HK |
dc.identifier.pmid | 21866334 | - |
dc.identifier.pmcid | PMC3178027 | - |
dc.identifier.scopus | eid_2-s2.0-80755172142 | en_HK |
dc.identifier.hkuros | 197807 | - |
dc.identifier.hkuros | 197719 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-80755172142&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 249 | en_HK |
dc.identifier.issue | 10 | en_HK |
dc.identifier.spage | 1439 | en_HK |
dc.identifier.epage | 1448 | en_HK |
dc.identifier.eissn | 1435-702X | en_US |
dc.identifier.isi | WOS:000295129000002 | - |
dc.publisher.place | Germany | en_HK |
dc.description.other | Springer Open Choice, 21 Feb 2012 | en_US |
dc.relation.project | Generation of corneal epithelial stem cells from human induced pluripotent stem cells (iPSC) and application for corneal epithelial tissue engineering | - |
dc.identifier.scopusauthorid | Wong, IYH=36490557200 | en_HK |
dc.identifier.scopusauthorid | Poon, MW=54584072400 | en_HK |
dc.identifier.scopusauthorid | Pang, RTW=54584075200 | en_HK |
dc.identifier.scopusauthorid | Lian, Q=7003399023 | en_HK |
dc.identifier.scopusauthorid | Wong, D=7401536078 | en_HK |
dc.identifier.citeulike | 9768635 | - |
dc.identifier.issnl | 0721-832X | - |